Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check7 days agoChange DetectedThe study page now shows recruitment is closed with 'No longer looking for participants', and new help sections were added to guide users (How to Read a Study Record, Common Questions, How to Join a Study). Additionally, a formatting label changed from 'Intervention / Treatment' to 'Intervention/Treatment' and the page revision is updated to v3.6.0, replacing v3.5.5.SummaryDifference0.3%

- Check14 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, signaling a minor site update; no study content or navigation elements appear to be changed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This indicates a patch-level update to the page's documentation or content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s technical revision/version tag was updated from v3.5.0 to v3.5.3 without changing the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedRELIVE trial publication citation added (Lancet Gastroenterol Hepatol, 2019) and the related erratum entry removed.SummaryDifference0.0%

- Check94 days agoChange DetectedAdds the term 'Hepatocellular carcinoma' to the page content and includes the Genetic and Rare Diseases Information Center as a resource. Updates the site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.